Saama (Platform)
by Saama
· Based in United States →
— #1 in AI Clinical Analytics
Customized based on individual needs.
Overview
Saama (Platform) is an AI-driven clinical analytics platform designed to automate and optimize various processes within clinical development and commercialization in the life sciences and healthcare sectors.
- What it does: The platform centralizes and standardizes clinical, operational, and financial data into a single location, known as the Data Hub. It uses AI, machine learning (ML), and generative AI (GenAI) to analyze data, identify discrepancies, and automate routine data review processes. Saama’s GenAI capabilities allow users to interact with complex clinical trial data using natural language to gain insights without requiring programming skills. The platform also includes tools for smart data quality, smart medical coding, operational insights, patient insights, and an agentic document generator.
- Who it is for: Saama (Platform) is primarily for professionals involved in clinical trials and healthcare operations, including data managers, medical monitors, clinical programmers, and study managers. It serves pharmaceutical and biotech companies, contract research organizations (CROs), and health networks.
- How it fits a clinical or practice workflow: The platform integrates into existing workflows to enhance operational efficiency throughout the drug development lifecycle, from study design and startup to conduct, biometrics, and regulatory submissions. It aims to streamline data management, accelerate data discovery, automate query generation, and facilitate comprehensive data reviews by enabling collaboration among study teams in a single environment. For healthcare providers, it offers solutions for digital care coordination, revenue cycle management, and hospital orchestration.
- Notable capabilities: Key features include its GenAI capabilities for natural language interaction with data, automated data quality checks, and the ability to generate custom data listings without programming. It also offers a holistic view of trial operations and patient progress in real time. Saama has developed over 90 AI models specifically for life sciences, trained on over 300 million data points. The platform also provides modular Clinical AI Agents designed for adaptability and integration with existing systems, with human oversight.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Clinical Data Foundation (Data Hub, Smart Data Quality (SDQ), Smart Medical Coding, Operational Insights, Patient Insights, Agentic Document Generator)
- Statistical Programming & Submissions (Biometrics Research and Analysis Information Network (BRAIN), BRAIN SCE, BRAIN SDTM, BRAIN Visualization, BRAIN Consortium)
- AI-powered analytics and reporting tools
- Generative AI capabilities for natural language interaction with data
- Automated data cleaning, review, and reconciliation (SDQ)
- Real-time holistic view of trial operations and patient progress
- AI-driven data mapping
- Centralized and standardized clinical, operational, and financial data
- Secure, role-based access and central administration
- Automated generation of submission-ready TLFs
Use Cases
- Automating clinical development processes
- Enhancing clinical trial efficiency and data management
- Accelerating clinical signal discovery and patient insights
- Streamlining commercialization processes in healthcare and commercial sectors
- Optimizing workflows and decision-making in life sciences organizations
- Transforming raw clinical data to CDISC SDTM standard
What Physicians Need to Know
Molecule Screening Capability
While Saama's platform focuses heavily on clinical development and analytics, direct mention of 'molecule screening capability' is not a primary highlight. Its strength lies in accelerating later-stage drug development through AI-powered clinical data management and insights.
Clinical Trial Matching
Saama's platform can assist in clinical trial matching by enabling customers to find and match newly diagnosed patients with specific genetic mutations to investigational drugs. It also helps in measuring trial diversity in real-time by linking epidemiological data to patient enrollment, allowing for proactive adjustments to meet diversity goals.
Real-World Evidence Analysis
Saama offers Real-World Evidence (RWE) solutions that harmonize data from multiple RWD sources (e.g., claims, EMR) into common structures like OMOP or Sentinel. This enables insights for cohort identification, clinical development feasibility, natural history of disease, population characteristics, and payer market focus. Saama's Active Safety Analytics for Pharma (ASAP) product leverages RWD for safety surveillance and pharmacovigilance.
Genomic Data Integration
Saama's ASAP product, designed for safety signal detection, has future capabilities to extend its real-world evidence platform to include genomic data sets. The platform also centralizes biomarker data to uncover deeper insights.
Literature Mining
Saama provides an AI-powered literature search engine that automates the search, review, and extraction of clinical entities from in-house and public sources, including clinical trial registries. It can identify relevant publications and extract medical entities such as patient population, intervention, outcomes, and inclusion/exclusion criteria, significantly accelerating the study design process.
Target Identification
While not explicitly stated as 'target identification' in the context of early drug discovery, Saama's ability to centralize and analyze biomarker data and provide insights into drug performance can indirectly support the understanding of disease mechanisms and potential targets.
Safety Signal Detection
Saama's Active Safety Analytics for Pharma (ASAP) is a validated pharmacovigilance solution that leverages the FDA's Sentinel Common Data Model and TreeScan methodology for detecting safety signals. It allows for identifying and evaluating potential new safety concerns during routine surveillance and post-market surveillance for MedTech, shifting from reactive to predictive risk mitigation.
Collaboration Features
Saama's platform is designed for cross-functional collaboration, enabling data management, medical review teams, and vendors to work together in a single environment. Features like Interactive Review Listings (IRL) allow teams to create custom listings, track queries, assign tasks, and manage vendors. Operational Insights also increase collaboration and transparency by providing a centralized view of data and allowing for task assignment and alerts.
Publication Support
Saama offers an AI-Powered Document Generator, a generative AI framework for clinical documentation. It streamlines workflows, reduces errors, and generates high-quality content based on study data, aligning with regulatory standards. It also assists medical writers with GenAI capabilities to identify and consolidate information for patient narratives and patient information leaflet generation.
Physician Tip
Leverage Saama's GenAI chat to interact with complex clinical trial data using natural language, eliminating delays in data analysis. Utilize the Patient Insights platform to actively monitor patient safety with AI-generated insights and customize alerts for clinically significant issues. Collaborate seamlessly with data managers and other team members within the platform for comprehensive data reviews and query management. For study design, use the AI-powered literature search engine to quickly extract relevant clinical entities and inform protocol development. Employ Real-World Evidence analysis to gain deeper insights into patient populations, natural history of disease, and comparative safety and efficacy.
Saama's platform is designed for seamless integration with existing systems and products, including major cloud providers (AWS, Azure) and leading EDC systems. It offers over 50 pre-built enterprise connectors to platforms like Snowflake, Databricks, Salesforce, and SAP. Saama also partners with companies like Datavant to connect disparate real-world and clinical datasets, enhancing insights for life sciences. The Data Hub supports ingestion of structured and unstructured data from various sources, including IRT/IVRS/RTSM, eCOA, Imaging, Sensors, eTMF, Safety, EMR/EHR, Labs, EDC, Finance, and CTMS.
Details
| Category | Drug Discovery & Research, Practice Analytics & BI |
| Pricing |
Customized based on individual needs.
|
| Deployment | Cloud-based (SaaS) |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
Unknown AI-estimated Saama's platform is not FDA cleared. However, it offers solutions that enhance compliance with regulations in clinical trials. |
| Integrations | |
| EHR | Not specified |
| Specialties | Hematology, Infectious Disease, Oncology |
What the Web Says
Saama (Platform) is an AI-driven clinical analytics platform designed for the healthcare and life sciences industries, aiming to accelerate clinical trials and drug development. It offers solutions for data aggregation, AI-powered insights, and automation of labor-intensive tasks, facilitating improved collaboration among clinical functions. The platform is praised for its strong talent, expertise in data needs, and good customer support.
Overall: PositiveStrengths
- Strong talent and expertise in data needs and solution design.
- Good customer support and provides detailed implementation information.
- Powerful analytics and data preparation features, enhancing insights and efficiency.
- High accuracy in data annotations for AI models.
- Automates key clinical development processes, reducing manual work and accelerating timelines.
- Facilitates collaboration among various clinical functions and simplifies data review.
Limitations
- Can be complex and hard to run, requiring extensive training or skilled personnel.
- Takes time to get enough resources from Saama to expedite progress.
- Occasional gaps of unplanned time off with the platform.
- Some users wish Saama would expand to cater to more clients.
- Not a mature company in terms of people management, processes, and career growth according to some employee reviews.
- Limited use of SAS for programmers, focusing more on Saama's own tools and Python.
Based on reviews from: G2, Slashdot, AWS, Capterra, Reddit, Indeed.com, Applied Clinical Trials Online
Last updated: 2026-08-07
Ratings & Reviews
Rate Saama (Platform)
Press & Coverage
Saama
Saama Redefines the Future of Clinical Development with Groundbreaking GenAI and Collaborative Platform Enhancements
Saama announced new features for its AI-driven platform, including generative AI chat and interactive review listings, to enhance cross-functional collaboration and accelerate clinical development. These features allow users to query data in natural language and track all queries in one location, aiming to reduce delays and operational silos.
2026-06
Saama
Saama Launches Industry's First AI-driven Data Platform to Accelerate Clinical Development
Saama launched a unified platform of SaaS-based products that leverages AI and machine learning to automate key clinical development processes and provide a comprehensive view of trial operations and patient progress. This platform aims to address challenges in clinical research, such as the cost of developing new treatments and the increasing volume of patient data.
2023-06
PR Newswire
Saama Introduces Modular and Adaptive AI Agents for Clinical Innovation
Saama introduced modular Clinical AI Agents designed to drive innovation and efficiency in clinical development by functioning with partial autonomy and human oversight. These agents integrate with the Saama Digital Study Platform or existing systems, addressing challenges highlighted by an MIT report on generative AI pilot failures.
2025-09
PR Newswire
Saama Unveils Industry-first AI-Powered Tables, Listings, and Figures (TLF) Analyzer to Transform Clinical Study Reporting
Saama announced its AI-Powered Tables, Listings, and Figures (TLF) Analyzer, an industry-first solution to streamline clinical study reporting by generating consistent, clinically meaningful narratives. The analyzer integrates protocol and SAP knowledge, uses natural language processing for intelligent search, and enables interactive refinement of summaries.
2025-10
Saama
Saama Wins u201cAI-based Life Sciences Solution of the Yearu201d Award in 2026 AI Breakthrough Awards Program
Saama received the u201cAI-based Life Sciences Solution of the Yearu201d award in the 2026 AI Breakthrough Awards, recognizing its leadership in AI clinical analytics. This award highlights Saama's decade of experience in developing and training AI models specifically for life sciences.
2026-06
Saama
Saama and Pfizer Expand Agreement to Integrate AI-Driven Data Solutions Across R&D Portfolio
Saama and Pfizer expanded their multi-year agreement to integrate AI-driven data solutions across Pfizer's R&D portfolio, aiming to expedite clinical research and regulatory submissions. This builds on their initial 2020 partnership that led to the Smart Data Quality (SDQ) solution, significantly reducing time to database lock.
2024-02
PMC (PubMed Central)
Revolutionizing clinical trials: the role of AI in accelerating medical breakthroughs
This article discusses how Saama's platform utilizes AI and machine learning to automate resource-intensive steps in clinical development, providing a comprehensive view of trial operations and patient status updates. Saama's platform, with over 90 AI models trained on more than 300 million data points, aims to increase productivity and accelerate medical breakthroughs.
2023-10
Applied Clinical Trials Online
Saama Launches AI-Driven Data Platform
Saama launched its unified AI-driven data platform, featuring SaaS-based products that apply AI and advanced analytics to clinical development processes. The platform includes solutions like Data Hub, Operational Insights, Patient Insights, Source to Submission (S2S), and Smart Data Quality (SDQ) to eliminate manual activities and streamline various functions.
2023-06
Videos
Product demos, reviews, and walkthroughs for Saama (Platform).
Loading videos...
Frequently Asked Questions
Saama (Platform) is an AI-driven data analytics platform designed to accelerate drug discovery and development. It can benefit your research by integrating and analyzing complex data from various sources, identifying patterns, and generating insights that can inform decision-making, potentially speeding up the drug discovery process and improving success rates.
Saama (Platform) is built with features to support compliance with regulatory requirements such as GDPR, HIPAA, and 21 CFR Part 11. It provides audit trails, data lineage, and robust security measures to ensure data integrity and traceability, which are crucial for regulatory submissions in drug discovery.
Yes, there are several other AI and data analytics platforms in the market that cater to drug discovery, such as IQVIA, Medidata, and Phesi. Each platform has its unique strengths and focuses, so evaluating your specific research needs and comparing features, scalability, and integration capabilities would be beneficial.
Pricing models for Saama (Platform) can vary depending on the scope of usage, data volume, and specific modules required. It often involves a subscription-based model, which may include tiered pricing. While it offers significant value, smaller research teams should inquire about specific packages or tailored solutions to assess cost-effectiveness for their budget and scale.
While powerful, limitations of Saama (Platform) can include the initial time and resources required for data integration and customization to specific research workflows. The quality of insights generated is also dependent on the quality and completeness of the input data. Additionally, like any AI platform, it's a tool to augment human expertise, not replace it.
Saama (Platform) is designed with integration capabilities to connect with various data sources, including LIMS, EHR, and other research databases. This allows for a comprehensive view of your research data, streamlining workflows and enabling more holistic analysis.
Saama (Platform) employs robust security measures, including encryption, access controls, and regular security audits, to protect sensitive drug discovery data. It also incorporates features for de-identification and anonymization of patient data to ensure privacy and compliance with relevant regulations.
Suggest an Edit →
| Last Verified: 2026-08-05 | First Added: 2026-08-05